Effects of gonadotropin administration on clinical outcomes in clomiphene citrate‐based minimal stimulation cycle IVF

Abstract

Abstract Purpose Exogenous gonadotropins (EGn) have been used occasionally in clomiphene citrate (CC)‐based minimal stimulation cycles to compensate insufficient secretion of endogenous gonadotropin; however, the effectiveness of EGn supplementation remains unknown. In the present study, we assessed whether EGn improved pregnancy outcomes in CC‐based minimal stimulation cycles. Methods A total of 223 patients treated with CC and EGn (CC‐EGn group) were matched one to one to patients treated with CC only (CC group) by propensity score matching. Embryonic and pregnancy outcomes were retrospectively compared between the groups. Results The numbers of retrieved oocytes, fertilized oocytes, cleaved embryos, and cryopreserved blastocysts were increased in the CC‐EGn group compared with the CC group. However, the cumulative live birthrate was comparable between the two groups. Although the increased number of retrieved oocytes was correlated significantly with improvement of the cumulative live birthrate in both groups, the correlation tended to be lower in the CC‐EGn group than in the CC group (odds ratio, 1.193 vs 1.553). Conclusions In CC‐based minimal stimulation cycles, the stimulation should be started with CC only, and EGn administration should be scheduled only if insufficient secretion of endogenous gonadotropin is observed in the late follicular phase.

Keywords

• clomiphene citrate
• cumulative live birthrate
• embryo transfer
• gonadotropins
• in vitro fertilization